Dyslipidemia Estimating CV Risk Flashcards
How do we asses cardiovascular risk? What is the phrase we use?
What is the %PROBABILITY this patient will experience the OUTCOME in the next X YEARS
Differentiate between framingham and ASCVD risk calculators. What do they calculate the risk of? Over/under estimate?
Framingham
- risk of heart attack or stroke, heart failure, angina, or intermittent claudication, and mortality
- includes “soft” outcomes which overestimates risk in most population
ASCVD
- calculates: heart attack or stroke (fatal or non-fatal), and mortality
- “HARD” outcomes only (less outcomes) -> leads to a lower risk calculation score overall
What kind of regression analysis do the risk score assessment use?
What kind of estimate is used?
What outcomes it is used for?
Multiple linear regression model
- Parameter estimate
Continuous outcome variables (normal distribution), ex.
- Days of hospitalization
- % risk of CVD outcomes
What regression model is used for death?
What kind of estimate is used?
What outcomes it is used for?
Logistic regression
- uses Odds ratio
- used for dichotomous outcomes, anything yes or no
What regression model is used for time-to-event (survival data)
What kind of estimate is used?
What outcomes it is used for?
Cox regression
- Hazard ratio (proportional hazards regression)
- Used for time to event such as time to first heart attack or how many months before death
What are the 3 phases in multivariable prognostic research?
- Development studies
- identifying important predictors and assigning relative weights to them to INTERNALLY validate model - Validation studies
- EXTERNAL validating the study by assessing predictive performance (discrimination) and improving performance (calibration) - Impact studies
- Quantifying if the new model truly improves clinical decision and clinical outcomes
What are common variables of risk calculators for CV risk factors?
- Age
- Gender
- total cholesterol
- HDL cholesterol
- systolic BP
- diabetes
- current smoking
What key variables are excluded in the following risk scores:
Framingham
QRISK2
ACC/AHA pooled cohort ASCVD risk
Framingham
- family history of CVD
QRISK2
- Diabetes
ACC/AHA pooled cohort ASCVD risk
- Family history
Is framingham risk used for primary or secondary prevention
Primary prevention
What are the guidelines for low, intermediate, & high risk.
Low: Under 10%
Intermediate: 10-20%
High: 20%
Which study did most of our knowledge on CVD risk factors come from?
Framingham study
What was the FRS cohort mainly included?
White, middle-class American individuals
Which population does the FRSH overestimate? Underestimate?
Overestimate:
- Japanese, Hispanic, mediterranean
Underestimate:
- south asians, Indians, Pakistan, Bangladesh
What was NOT included in the FRS
- No socioecomonic status
- not designed for diabetes
- No family history (due to recall bias, important)
- Novel biomarkers: (coronary artery calcification CAC, CRP, BNP, however did not really impact)
Define B-type Natriuretic peptide biomarker
A cardiac hormone synthesized in the LV in response to inc ventricular VOLULE or inc pressure in ventricular WALL STRESS
When do we consider biomarkers in risk scores?
When they are intermediate-risk
- can make them be pushed to high risk
ACC/AHA inclusion criteria
- Caucasian and African American patients
- Diabetes as a yes/no (not severity)
What was not included in the ACC/AHA criteria
- Family history of premature CVD
(Dad <55 and Mom <65)
Does ACC/AHA study over/under estimate? By how much
50% overestimation
End points of ACC/AHA study? What are they looking for?
Fatal + non-fatal MI
Stroke
CHD death
What does the SCORE study look at?
The vascular age compared to your actual age
How often should you use the risk score on patients? What age group?
Every 5 years for patients aged 40-75
What is the approach to risk score (5 steps)
- Determine if patient has 1 or more CVD risk factors (HTN, smoking, DM, premature family history, CKD, obesity)
- Obtain lipid panel for 20+ age
- For primary prevention 40-79yo, use FRS FIRST
- for patients 20-39 input age as 40 - Do 30 years or lifetime if risk is low
- Do ASCVD or SCORE
- Repeat every 5 years or when a major change happens
- Convey results to clinicians and patients (include overestimation)